BIB Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Full metrics table
| Category | Equity - Leveraged / Inverse | Expense | 0.95% | Return% 1Y | 68.16% | Total Holdings | 257 | Perf Week | 1.17% | Volume | 4,610 |
| Asset Type | Equities (Stocks) | AUM | $96M | Return% 3Y | 37.05% | NAV | $111.12 | Perf Month | -0.31% | Avg Volume | 0.01M |
| ETF Type | US Equities | Dividend TTM | $0.23 (0.2%) | Return% 5Y | 5.64% | 52W High | -8.8% | Perf Quarter | 16.78% | Rel Volume | 0.48 |
| Active/Passive | Passive | Div Gr. 3/5Y | 72.69% - | Return% 10Y | 10.84% | 52W Low | 70.78% | Perf Half Y | 42.95% | Prev Close | $111.07 |
| IPO | 2010/4/8 | Flows% 1M | 2.42% | Return% SI | 17.87% | RSI (14) | 55.44 | Perf YTD | 44.49% | Price | $115.27 |
| Beta | 1.27 | Flows% 3M | 3.17% | Flows% YTD | -13.07% | Flows% 1Y | -7.97% | Perf Year | 66.86% | Volatility(W/M) | 3.08% 3.38% |
| SMA20 | 4.85% | SMA50 | 1.28% | SMA200 | 22.24% | ATR | 4.38 | ||||
ProShares Ultra Nasdaq Biotechnology seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
It moves 2x the daily move of the index
Its value erodes over time. It is built for trades of a day or two, not for holding.
The top 10 make up 48% of the fund
GILD Gilead Sciences, Inc. 4.66% 4 
VRTX Vertex Pharmaceuticals, Inc. 4.65% 5 
AMGN Amgen, Inc. 4.48% 6 
REGN Regeneron Pharmaceuticals, Inc. 3.21% 
ALNY Alnylam Pharmaceuticals, Inc. 2.01% 9 
RVMD Revolution Medicines, Inc. 1.57% 10 
BIIB Biogen, Inc. 1.44% Largest sectors first.
Over the past 1 year, on the higher side
9% below its 1-year high.
Traded less than usual. That is 48% of its average volume.
Holding long would have paid off
Bought 5 years ago, your return today would be +30.6%. The S&P 500 did +70% over the same period.
Tap to view numbers
The price swings wildly
At its worst (February 2021) it fell 66% and took 455 days to recover.
Tap to view numbers
The dividend is on the small side
Pays 0.20% annually in dividends.
Tap to view numbers
A lot of money is flowing out
Over the past year, money equal to 8.0% of assets left.
Tap to view numbers
LABU Direxion Daily S&P Biotech Bull 3X ETF 586M 
MRNY YieldMax MRNA Option Income Strategy ETF 222M 
LABD-1× Direxion Daily S&P Biotech Bear 3X ETF 78M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
BIS-1× ProShares UltraShort Nasdaq Biotechnology -2x Shares 2M 
TQQQ ProShares UltraPro QQQ 3x Shares 0.78% 
SOXL Direxion Daily Semiconductor Bull 3X ETF 0.75% 
QLD ProShares Ultra QQQ 2x Shares 0.89% 
SSO ProShares Ultra S&P500 2x Shares 0.84% 
SPXL Direxion Daily S&P 500 Bull 3X ETF 0.84% 
TOPW Roundhill Top WeeklyPay ETF 0.32% 
FNGU MicroSectors FANG+ 3X Leveraged ETNs 0.35% 
NRGU MicroSectors U.S. Big Oil 3 Leveraged ETNs 0.35% 
FAQ
How many holdings does BIB have?
BIB holds a total of 257 securities, with an AUM of approximately $96M.
Does BIB pay dividends (distributions)?
BIB's distribution yield is approximately 0.20%.
What is the 52-week high and low for BIB?
BIB has recorded a 52-week high of $126.40 and a low of $67.50.
